lobbying_activities: 668960

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
668960	c65383ae-8153-414b-b5f4-de16517ea45c	Q3	INVARIANT LLC	314237	ELI LILLY AND COMPANY	2008	third_quarter	MED	H.R. 5629, Pathway for Biosimilars Act; H.R. 1038/S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007; S. 1505, Affordable Biologics for Consumers Act; S. 1695, Biologics Price Competition and Innovation Act of 2007, as they pertain to the term of data exclusivity for biologic drugs.	HOUSE OF REPRESENTATIVES	50000		0	0	2008-10-16T11:24:21-04:00